Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
Japan flag Japan · Delayed Price · Currency is JPY
1,299.00
+20.00 (1.56%)
Jul 21, 2026, 1:43 PM JST

TYO:2395 Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, TYO:2395 stock has a consensus rating of "Buy" and an average price target of ¥1,640. The average 1-year stock price forecast is 26.25% higher than the current stock price, while the lowest is ¥1,280 (-1.46%) and the highest is ¥2,000 (+53.96%).

Price Target: ¥1,640 (+26.25%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥1,280¥1,640¥1,640¥2,000
Change-1.46%+26.25%+26.25%+53.96%
* Price targets were last updated on Jun 1, 2026.

Analyst Ratings

The average analyst rating for TYO:2395 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingNov '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy111111
Buy111110
Hold000001
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Nomura
No rating
Nomura
Hold
Downgrades
¥2,090¥1,280
HoldDowngrades¥2,090¥1,280-1.46%Jun 1, 2026
Unknown Analyst
Tokai-Tokyo Securities
No rating
Tokai-Tokyo Securities
Buy
Maintains
¥2,000
BuyMaintains¥2,000+53.96%May 26, 2026

Financial Forecast

Revenue This Year
38.37B
from 32.52B
Increased by 17.98%
Revenue Next Year
40.96B
from 38.37B
Increased by 6.75%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
17.75B25.09B26.45B32.41B32.52B38.37B
Revenue Growth
17.46%41.37%5.42%22.54%0.34%17.98%
Operating Income
4.20B5.25B4.16B2.99B2.65B3.22B
Net Income
7.13B6.06B5.53B4.92B4.57B3.95B
Dividend / Share
30.0050.0050.0050.0050.0050.00
Dividend Growth
-66.67%----
Free Cash Flow
2.47B-2.73B-7.43B-5.52B-1.80B-4.33B
No. Analysts
-----2
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High38.4B
Avg38.4B
Low38.3B

Revenue Growth

Revenue Growth202720282029
High
18.1%
Avg
18.0%
Low
17.9%

EPS Forecast

EPS202720282029
High-
Avg-
Low-

EPS Growth

EPS Growth20282029
High-
Avg-
Low-